cas 315203-39-5|| where to buy 1-(2,6-dichlorobenzyl)-3-(pyrrolidin-1-ylmethyl)-1H-indazol-6-amine

Nombre del producto:1-(2,6-dichlorobenzyl)-3-(pyrrolidin-1-ylmethyl)-1H-indazol-6-amine

IUPAC Name:1-[(2,6-dichlorophenyl)methyl]-3-[(pyrrolidin-1-yl)methyl]-1H-indazol-6-amine

Unidad de embalaje	Stock disponible	Precio($)	Cantidad
CM124911-250mg	in stock	Ǡǆǲ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 315203-39-5 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :315203-39-5; Fórmula molecular:C19H20Cl2N4; Punto de fusión:-; Código de sonrisas:NC1=CC2=C(C=C1)C(CN3CCCC3)=NN2CC4=C(Cl)C=CC=C4Cl; Densidad:

: Número de catálogo:CM124911; Peso molecular:375.3; Punto de ebullición:555.1±50.0°C at 760 mmHg; Nº Mdl:MFCD03093364; Almacenamiento:Keep in dark place, store at 2-8°C.

: Indazoles; Indazoles are a class of organic heterocyclic compounds, also known as 1,2-diazaindene and benzopyrazole. Indazole is a good bioisomer of phenol, which is more lipophilic than phenol and less prone to phase I and II metabolism. Indazole derivatives have a wide range of biological activities, and it has been confirmed that indazole compounds have anti-tumor, analgesic, anti-inflammatory and other drug activities. Anticancer is the most important application field of indazole drugs. Renal cell carcinoma, solid tumor, nausea and vomiting caused by chemotherapy and leukemia are the main indications of this structural backbone drug.

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.